# Modified Bases in tRNA: Functions, Biogenesis, and Disease

## Introduction to Modified Bases in tRNA

Transfer RNA (tRNA) is the adaptor molecule that decodes messenger RNA (mRNA) into protein sequence. Every tRNA contains a specific anticodon that pairs with a codon on the mRNA, and a 3′ acceptor stem where an amino acid is attached by aminoacyl-tRNA synthetases. What many students first learn as a simple cloverleaf of about 76 nucleotides is, in reality, one of the most chemically diverse RNA molecules in the cell. Beyond the four canonical ribonucleosides—adenosine, guanosine, cytidine, and uridine—tRNA molecules carry a remarkable collection of chemically altered nucleosides known collectively as **modified bases**.

### What Are Modified Bases?

A modified base in tRNA is a nucleoside that has been enzymatically altered after transcription. These alterations can be as simple as the addition of a single methyl group or as elaborate as the construction of multi-ring hypermodified structures requiring dozens of enzymatic steps. The modification occurs post-transcriptionally, meaning the tRNA gene encodes only the standard four bases; the chemical diversity is added by enzymes that recognize specific positions within the tRNA structure.

Modified bases are not evenly distributed across the tRNA molecule. They cluster in two functionally critical regions: the **anticodon loop**, particularly at positions 34 (the wobble position) and 37 (immediately 3′ of the anticodon), and the **TΨC arm** and **D arm**, which contribute to the overall three-dimensional folding of the molecule. This positional bias is not accidental—it reflects the two major functions of tRNA modifications: ensuring accurate and efficient decoding of mRNA, and maintaining the structural integrity of the tRNA itself.

### Historical Perspective

The discovery of modified bases in tRNA predates the elucidation of the genetic code itself. In the 1950s, while analyzing yeast tRNA, researchers detected small amounts of nucleosides that did not match the four canonical bases. The first identified modification was pseudouridine (Ψ), an isomer of uridine in which the base is attached to the ribose via a carbon–carbon bond rather than a nitrogen–carbon bond. Over the following decades, advances in chromatographic separation and mass spectrometry revealed an ever-growing catalog of modified nucleosides. Today, more than 150 distinct modified bases have been characterized across all domains of life, with tRNA harboring the greatest diversity of any RNA species. The functional significance of these modifications became clear through genetic studies in bacteria and yeast, where loss of specific modification enzymes produced defects in growth, translation accuracy, and stress responses.

## Chemical Diversity of tRNA Modifications

The chemical modifications found in tRNA can be grouped into several broad categories based on the type of chemical change introduced. Understanding this diversity is essential because each modification type has distinct biochemical properties and functional consequences.

### Methylations

Methylation is the most common and chemically simplest tRNA modification. A methyl group (–CH₃) is added to various positions on the base or the 2′-hydroxyl group of the ribose. Methylations are catalyzed by **methyltransferases** that use S-adenosylmethionine (SAM) as the methyl donor.

Base methylations include 1-methyladenosine (m¹A), 1-methylguanosine (m¹G), 5-methylcytidine (m⁵C), and 3-methylcytidine (m³C). These modifications alter base-pairing properties by changing hydrogen-bonding patterns or introducing steric bulk. For example, m¹A at position 58 of the TΨC loop is nearly universal in tRNA and contributes to the stability of the elbow region of the tRNA tertiary structure.

Ribose methylations, such as 2′-O-methylcytidine (Cm) and 2′-O-methylguanosine (Gm), occur on the 2′-hydroxyl group of the ribose sugar. These modifications increase the hydrophobicity of the nucleotide and protect the tRNA from alkaline hydrolysis and nuclease attack. Ribose methylation also stabilizes the C3′-endo sugar pucker conformation, which favors the A-form RNA helix.

### Pseudouridine and Other Isomerizations

Pseudouridine (Ψ) is the most abundant modified nucleoside in tRNA and is often called the "fifth base." It is formed by an isomerization reaction in which the glycosidic bond of uridine is broken and re-formed between the C5 carbon of uracil and the ribose. This creates an extra hydrogen-bond donor on the N1 position of the base. Pseudouridine can form an additional hydrogen bond with a phosphate backbone, increasing base stacking and rigidifying the local RNA structure.

In tRNA, pseudouridine is found at several positions, most notably position 55 in the TΨC loop, which is present in virtually all tRNAs and gives the loop its name. Pseudouridine at position 55 stabilizes the interaction between the TΨC loop and the D loop, a key tertiary contact that maintains the L-shaped three-dimensional fold of tRNA.

Other isomerization modifications include 3-methyluridine (m³U) and 5-methyluridine (ribothymidine, m⁵U), which are methylated derivatives of uridine rather than true isomers.

### Thiolation and Selenation

Thiolation involves the replacement of an oxygen atom with sulfur. The most common thiolated base in tRNA is 4-thiouridine (s⁴U), found at position 8 in many bacterial tRNAs. This modification acts as a photosensor: upon exposure to near-UV light, s⁴U forms crosslinks with adjacent cytidine, triggering a growth arrest response in bacteria.

More functionally significant is 2-thiouridine (s²U) at the wobble position 34 of tRNAs that decode lysine (Lys), glutamic acid (Glu), and glutamine (Gln) codons. The sulfur substitution restricts the conformational flexibility of the uridine, preventing mispairing with pyrimidines and ensuring that these tRNAs read only their cognate purine-ending codons. In mammalian mitochondria, the 2-thio modification is accompanied by a 5-taurinomethyl group, forming 5-taurinomethyl-2-thiouridine (τm⁵s²U), which is critical for mitochondrial translation.

Selenation, the incorporation of selenium, occurs in a small number of tRNAs. 5-methylaminomethyl-2-selenouridine (mnm⁵se²U) is found in bacterial tRNA^Glu and tRNA^Lys, where selenium replaces sulfur at the 2-position. The seleno modification confers even greater conformational restriction than the thio version.

### Hypermodified Bases

Hypermodified bases are complex structures built from a canonical base through multiple enzymatic steps. These modifications are found predominantly at position 37, immediately 3′ of the anticodon, where they play critical roles in maintaining the reading frame during translation.

**N⁶-isopentenyladenosine (i⁶A)** is formed by the addition of an isopentenyl group derived from dimethylallyl pyrophosphate (DMAPP) to the N⁶ position of adenosine. This modification is found in tRNAs that read codons beginning with uridine (UNN codons). The bulky hydrophobic isopentenyl group protrudes from the anticodon loop and stabilizes the stacking interaction between position 37 and the first base of the anticodon, preventing frameshifting.

**Wyosine** and its derivatives, including wybutosine (yW) in yeast and 4-demethylwyosine (imG-14) in archaea, are tricyclic structures formed from guanosine through a multi-step pathway. Wybutosine at position 37 of tRNA^Phe prevents frameshifting during the decoding of phenylalanine codons (UUU and UUC) by stabilizing the codon–anticodon interaction.

**Queuosine (Q)** is a hypermodified base found at the wobble position 34 of tRNA^Asp, tRNA^Asn, tRNA^His, and tRNA^Tyr. Uniquely, queuosine is synthesized by bacteria and acquired by eukaryotes through dietary intake or gut microbiota. The base is a 7-deazaguanosine derivative with a cyclopentenediol side chain. Queuosine improves the accuracy of decoding and is involved in cellular responses to oxidative stress.

**Inosine (I)** is formed by the deamination of adenosine at position 34. This modification is catalyzed by adenosine deaminases acting on tRNA (ADATs). Inosine can pair with U, C, or A, expanding the decoding capacity of a single tRNA. In eukaryotes, inosine at the wobble position allows a single tRNA to decode multiple synonymous codons.

The table below summarizes the major classes of tRNA modifications, their typical positions, and their primary functions.

| Modification Type | Examples | Typical Positions | Primary Function |
|---|---|---|---|
| Methylation | m¹A, m⁵C, m¹G, Cm, Gm | Multiple (8, 9, 18, 58) | Structural stability, protection from nucleases |
| Isomerization | Pseudouridine (Ψ) | 55, 32, 39 | Structural stabilization, enhanced stacking |
| Thiolation | s²U, s⁴U | 8, 34 | Codon discrimination, UV sensing |
| Hypermodification | i⁶A, wybutosine, queuosine | 34, 37 | Reading frame maintenance, decoding accuracy |
| Deamination | Inosine (I) | 34 | Wobble decoding expansion |

## Enzymatic Machinery and Biogenesis Pathways

The installation of modified bases in tRNA is carried out by a dedicated set of enzymes. These enzymes are often classified as **writers** (enzymes that install modifications), **readers** (proteins that recognize modifications), and **erasers** (enzymes that remove modifications). This conceptual framework, borrowed from the study of histone modifications, helps organize the complex biochemistry of tRNA modification.

### tRNA Modification Enzymes

Each modification is installed by a specific enzyme or enzyme complex. The names of these enzymes typically reflect the modification they catalyze. For example, **Trm1** catalyzes the formation of N²,N²-dimethylguanosine (m²₂G) at position 26, while **Trm2** is responsible for m⁵U at position 54. In bacteria, the enzyme **TruB** converts uridine to pseudouridine at position 55; the human ortholog is encoded by the *PUS1* gene.

Some modification enzymes are multisubunit complexes. The **Elongator complex** in yeast and humans is a six-subunit complex (Elp1–Elp6) that catalyzes the first step of the formation of 5-methoxycarbonylmethyl-2-thiouridine (mcm⁵s²U) at the wobble position of tRNA^Lys, tRNA^Glu, and tRNA^Gln. The Elongator complex is remarkable because it functions in the nucleus and requires the prior modification of the tRNA by other enzymes, illustrating the sequential and coordinated nature of modification pathways.

The biosynthesis of hypermodified bases often requires multiple enzymes acting in sequence. For example, the formation of wybutosine at position 37 of tRNA^Phe requires five enzymatic steps in yeast, starting with the methylation of guanosine by **Trm5** to form m¹G, followed by reactions catalyzed by **Tyw1**, **Tyw2**, **Tyw3**, and **Tyw4**. Each enzyme recognizes the partially modified tRNA as its substrate, and the pathway is strictly ordered.

### Substrate Recognition and Specificity

How do modification enzymes recognize their specific target positions within a tRNA? The answer lies in the three-dimensional structure of tRNA. Most modification enzymes recognize features of the tRNA beyond the immediate target nucleotide, including the local secondary structure, the identity of neighboring bases, and the overall tertiary fold.

For example, the enzyme **Trm4** (which catalyzes m⁵C at position 48 in yeast) recognizes the length of the variable loop and the identity of the base at position 45. Similarly, the pseudouridine synthase **TruB** recognizes the TΨC loop structure and requires the correct sequence context around position 55.

Some enzymes recognize the tRNA before it is fully processed. In eukaryotes, tRNA modifications can occur in the nucleus during transcription and processing, or in the cytoplasm after export. The compartmentalization of modification enzymes adds another layer of regulation. For instance, the m¹G37 methyltransferase **Trm5** is nuclear in yeast, while the anticodon loop modification enzymes are cytoplasmic. This spatial separation ensures that modifications occur in the correct order.

### Dynamic Regulation of Modifications

Although tRNA modifications were historically viewed as static, constitutive features, it is now clear that they can be dynamically regulated in response to cellular conditions. The levels of certain modifications change under stress, during different growth phases, and in response to nutrient availability.

One well-studied example is the regulation of mcm⁵s²U at the wobble position of tRNA^Lys^UUU. Under oxidative stress, the levels of this modification increase, enhancing the translation of genes enriched in lysine codons that are required for the stress response. This regulation is mediated by the **Elongator complex**, whose activity is modulated by phosphorylation.

Another example is the **tRNA methyltransferase 10C (TRMT10C)**, which is part of the mitochondrial RNase P complex. TRMT10C catalyzes the methylation of mitochondrial tRNA at position 9. Mutations in *TRMT10C* cause a form of mitochondrial disease, and the enzyme's activity is regulated by the metabolic state of the mitochondrion.

The removal of tRNA modifications is less well understood than their installation. However, several **eraser** enzymes have been identified. The **AlkB** family of dioxygenases in bacteria and eukaryotes can demethylate m¹A and m³C in tRNA. In humans, **ALKBH1** demethylates m¹A at position 58 of tRNA, and **ALKBH3** can remove m¹A from tRNA under certain conditions. The existence of erasers suggests that some tRNA modifications are reversible and that their dynamic regulation is biologically meaningful.

## Functional Roles in Translation and Cellular Processes

The functional importance of modified bases in tRNA cannot be overstated. These modifications influence nearly every aspect of tRNA biology, from the folding and stability of the molecule to the accuracy and efficiency of translation. They also connect tRNA to broader cellular processes, including stress responses and signaling.

### Impact on tRNA Structure and Stability

The three-dimensional structure of tRNA is maintained by a network of non-canonical base pairs and stacking interactions. Modified bases contribute to this network by stabilizing specific conformations and preventing alternative, non-productive folds.

Pseudouridine at position 55 is a key structural element. The additional hydrogen bond donor of pseudouridine allows it to form a more stable interaction with the backbone, rigidifying the TΨC loop. This rigidity is transmitted to the D loop through the tertiary interaction between positions 55 and 18, stabilizing the elbow of the L-shaped tRNA structure.

Methylations also contribute to structural stability. The m¹A at position 58 forms a reverse Hoogsteen base pair with U54, which is essential for the correct folding of the TΨC loop. In the absence of this modification, tRNAs are more susceptible to degradation by nucleases and are less efficiently aminoacylated.

Ribose methylations (2′-O-methylations) stabilize the C3′-endo conformation of the ribose, which is the conformation required for A-form RNA helices. This stabilization is particularly important in the anticodon stem, where it helps maintain the correct geometry for codon recognition.

### Codon-Anticodon Interactions and Wobble

The most direct function of tRNA modifications is in the decoding of mRNA codons. The **wobble position** (position 34) and position 37 are the two most heavily modified positions in tRNA, and their modifications have profound effects on codon–anticodon interactions.

The wobble hypothesis, proposed by Francis Crick in 1966, states that the base at position 34 of the anticodon can pair with multiple bases at the third position of the codon. This flexibility allows a single tRNA to decode multiple codons. However, the wobble pairing must be constrained to prevent misreading. Modified bases at position 34 provide this constraint.

For example, the 2-thio modification (s²U) at position 34 of tRNA^Lys, tRNA^Glu, and tRNA^Gln restricts the conformational flexibility of uridine. The sulfur atom at the 2-position prevents the uridine from adopting the *anti* conformation required for pairing with pyrimidines, ensuring that these tRNAs read only their cognate purine-ending codons (AAG, GAG, and CAG, respectively). Without this modification, these tRNAs would misread near-cognate codons, leading to translational errors.

Inosine at position 34 provides the opposite effect: it expands decoding capacity. Inosine can pair with U, C, and A, allowing a single tRNA with inosine at the wobble position to decode three different codons. This is particularly important in eukaryotes, where the number of tRNA genes is limited and codon degeneracy must be accommodated by fewer tRNA species.

Modifications at position 37 also influence codon–anticodon interactions. The hypermodified bases at this position (i⁶A, wybutosine, and their derivatives) stack on top of the first base of the anticodon, stabilizing the interaction between the anticodon and the codon. This stacking prevents the anticodon from "slipping" relative to the codon, which would cause frameshifting.

### Translation Fidelity and Speed

The combined effects of modifications on codon–anticodon interactions result in two related outcomes: translation fidelity (accuracy) and translation speed (efficiency). These two parameters are in tension—increasing fidelity often decreases speed, and vice versa.

Modified bases at the wobble position and position 37 enhance fidelity by preventing near-cognate codon misreading and by maintaining the reading frame. For example, yeast strains lacking the wybutosine modification at position 37 of tRNA^Phe exhibit increased +1 frameshifting, leading to the production of aberrant proteins. Similarly, bacteria lacking the m¹G37 modification (catalyzed by TrmD) show severe growth defects due to frameshifting at codons decoded by tRNA^Pro.

Modifications also affect translation speed. The 2-thio modification at position 34 increases the rate of GTP hydrolysis by the ribosome during the decoding process, making translation more efficient. Conversely, the absence of certain modifications can slow translation, particularly at codons that require wobble pairing.

The relationship between modifications and translation speed is particularly important under stress conditions. When cells are stressed, the levels of certain modifications change, altering the translation of specific mRNAs. For example, under amino acid starvation, uncharged tRNAs accumulate, and the modification status of the anticodon loop changes, leading to the preferential translation of mRNAs encoding stress-response proteins.

### Beyond Translation: Stress Responses and Signaling

Modified bases in tRNA are not solely concerned with translation. They also participate in [cellular signaling](/knowledge/molecular-biology/cellular-signaling) and stress responses through several mechanisms.

One mechanism involves the **tRNA fragments** (tRFs) and **tiRNAs** (tRNA halves) that are generated by cleavage of mature tRNAs under stress conditions. The modification status of tRNAs affects their susceptibility to cleavage by angiogenin and other ribonucleases. For example, tRNAs lacking certain modifications are more easily cleaved, generating fragments that inhibit translation and promote cell survival under stress.

Another mechanism involves the direct sensing of tRNA modification levels by [cellular signaling](/knowledge/molecular-biology/cellular-signaling) pathways. In bacteria, the **ToxT** and **ToxS** systems respond to the modification status of specific tRNAs to regulate virulence gene expression. In eukaryotes, the **general amino acid control (GAAC)** pathway responds to uncharged tRNAs, which accumulate when amino acids are limiting. The uncharged tRNAs bind to the kinase Gcn2, activating a signaling cascade that leads to the upregulation of amino acid biosynthetic genes.

Finally, tRNA modifications can affect the interaction between tRNAs and other proteins. For example, the modification status of tRNA influences its recognition by aminoacyl-tRNA synthetases, affecting the efficiency of [tRNA charging](/knowledge/molecular-biology/trna-charging). This provides a link between tRNA modifications and the overall rate of protein synthesis.

## Methods to Detect and Analyze tRNA Modifications

The study of tRNA modifications requires specialized techniques capable of detecting and quantifying chemically altered nucleosides. These methods range from classical biochemical approaches to modern high-throughput sequencing technologies.

### Mass Spectrometry Approaches

Mass spectrometry (MS) is the gold standard for the identification and quantification of tRNA modifications. The approach typically involves the following steps:

1. **Isolation of tRNA**: Total RNA is extracted from cells or tissues, and tRNA is purified by size exclusion chromatography or denaturing polyacrylamide gel electrophoresis.
2. **Enzymatic digestion**: The purified tRNA is digested to single nucleosides using a combination of nucleases (e.g., nuclease P1) and phosphatases (e.g., [alkaline phosphatase](/knowledge/molecular-biology/alkaline-phosphatase)).
3. **Liquid chromatography separation**: The nucleoside mixture is separated by reverse-phase high-performance liquid chromatography (HPLC).
4. **Mass spectrometric detection**: The separated nucleosides are ionized and detected by mass spectrometry. Each modified nucleoside has a characteristic mass, allowing identification. Tandem mass spectrometry (MS/MS) provides additional structural information.

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can detect and quantify dozens of modified nucleosides in a single run. The sensitivity of modern instruments allows the detection of modifications present at very low stoichiometry. However, MS approaches require relatively large amounts of tRNA and cannot easily determine the position of a modification within a specific tRNA.

### High-Throughput Sequencing Methods

The development of high-throughput sequencing methods for tRNA modifications has been challenging because reverse transcriptase (RT) often reads through modified bases, and the modifications themselves do not directly produce sequencing signals. However, several strategies have been developed to overcome this limitation.

**Pseudo-seq** and **Ψ-seq** are methods for detecting pseudouridine. These methods exploit the fact that pseudouridine forms stable adducts with certain chemicals, such as N-cyclohexyl-N′-β-(4-methylmorpholinium)ethylcarbodiimide (CMC). The CMC adduct causes RT to pause or stop, generating a truncation that can be mapped to the position of pseudouridine.

**m¹A-seq** and **m⁵C-seq** use antibody-based enrichment followed by sequencing. Antibodies specific for m¹A or m⁵C are used to immunoprecipitate tRNA fragments containing the modification, which are then sequenced to identify the modified positions.

**DM-tRNA-seq** (demethylase-treated tRNA sequencing) is a method for detecting m¹A. The approach uses the AlkB demethylase to remove m¹A, converting it back to adenosine. By comparing the sequencing results of treated and untreated samples, the positions of m¹A can be inferred.

More recently, **[nanopore sequencing](/blog/guides/nanopore-sequencing)** has emerged as a promising approach for detecting tRNA modifications. [Nanopore sequencing](/blog/guides/nanopore-sequencing) measures changes in ionic current as RNA passes through a protein pore. Modified bases produce characteristic current signatures that can be distinguished from canonical bases. This approach has the advantage of detecting modifications in full-length tRNA molecules without the need for amplification or chemical treatment.

### Classical Biochemical Techniques

Before the advent of modern sequencing and MS methods, tRNA modifications were studied using classical biochemical techniques. These methods are still useful for specific applications.

**Two-dimensional thin-layer chromatography (2D-TLC)** separates radiolabeled nucleotides based on their charge and hydrophobicity. This method was used to discover many tRNA modifications and is still used to analyze the modification status of tRNAs from cells labeled with radioactive precursors.

**Primer extension assays** exploit the fact that certain modifications cause RT to pause or stop. By comparing the extension products of reverse transcription on modified and unmodified tRNAs, the positions of modifications can be mapped. This method is particularly useful for detecting modifications that block RT, such as m¹A and m³C.

**Northern blotting** with modification-specific antibodies can detect the presence of a modification in a specific tRNA. This approach is less quantitative than MS but can be used to compare modification levels between different samples.

## Modified Bases in tRNA and Human Disease

Defects in tRNA modification enzymes are associated with a growing number of human diseases. These conditions range from rare mitochondrial disorders to common cancers, highlighting the broad physiological importance of tRNA modifications.

### Mitochondrial tRNA Modifications and Disease

Mitochondrial tRNAs are particularly rich in modified bases, and defects in mitochondrial tRNA modification are a major cause of mitochondrial disease. The human [mitochondrial genome](/blog/guides/mitochondrial-genome) encodes 22 tRNAs, and many of these carry modifications that are essential for their function.

**MELAS syndrome** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) is caused by mutations in the *MT-TL1* gene, which encodes mitochondrial tRNA^Leu(UUR). The most common mutation (m.3243A>G) affects the modification of the wobble position, specifically the formation of 5-taurinomethyl-2-thiouridine (τm⁵s²U). This modification is required for the accurate decoding of UUR codons. In its absence, mitochondrial translation is impaired, leading to a deficiency in the respiratory chain complexes that contain mitochondrially encoded subunits.

**MERRF syndrome** (Myoclonic Epilepsy with Ragged Red Fibers) is caused by mutations in *MT-TK*, which encodes mitochondrial tRNA^Lys. The m.8344A>G mutation affects the modification of the wobble position of tRNA^Lys, impairing the decoding of lysine codons and causing a severe defect in mitochondrial protein synthesis.

Mutations in the nuclear-encoded enzymes that modify mitochondrial tRNAs also cause disease. For example, mutations in *TRMT10C* (which encodes a component of the mitochondrial RNase P complex) cause a form of mitochondrial disease characterized by developmental delay, lactic acidosis, and respiratory chain deficiency. Similarly, mutations in *GTPBP3* and *MTO1*, which are involved in the formation of τm⁵s²U, cause combined oxidative phosphorylation deficiency.

### Neurological and Developmental Disorders

tRNA modifications are particularly important in the nervous system, where accurate translation is critical for neuronal function. Several neurological disorders are caused by defects in tRNA modification enzymes.

**X-linked intellectual disability** is associated with mutations in the *FTSJ1* gene, which encodes a 2′-O-methyltransferase that modifies tRNA. The mechanism by which FTSJ1 mutations cause intellectual disability is not fully understood, but it is thought to involve impaired translation of specific mRNAs required for neuronal development and function.

**Autism spectrum disorder** has been linked to mutations in the *ELP2* and *ELP4* genes, which encode subunits of the Elongator complex. The Elongator complex is required for the formation of mcm⁵s²U at the wobble position of tRNA^Lys, tRNA^Glu, and tRNA^Gln. Defects in Elongator function lead to impaired translation of proteins involved in neuronal migration and synaptic function.

**Pontocerebellar hypoplasia** is a group of neurodegenerative disorders caused by mutations in genes involved in tRNA processing and modification. For example, mutations in *CLP1*, which is involved in tRNA splicing, cause a form of pontocerebellar hypoplasia with motor neuron degeneration.

### Cancer and Other Pathologies

Altered tRNA modification levels are observed in many cancers, and some tRNA modification enzymes have been identified as oncogenes or tumor suppressors.

**NSUN2** (which catalyzes m⁵C at position 48 of tRNA) is overexpressed in several cancers, including breast, colorectal, and bladder cancer. The oncogenic activity of NSUN2 is thought to be mediated by its effects on the stability of tRNA fragments, which can promote [cell proliferation](/blog/guides/cell-proliferation) and survival.

**TRMT12** (which catalyzes the formation of wybutosine in tRNA^Phe) is overexpressed in breast cancer, and its expression correlates with poor prognosis. The mechanism is not fully understood, but it may involve altered translation of mRNAs encoding proteins that regulate cell proliferation.

**ALKBH3** (which demethylates m¹A in tRNA) is overexpressed in pancreatic and lung cancers. The demethylase activity of ALKBH3 promotes cancer cell survival by preventing the accumulation of modified tRNAs that would otherwise trigger apoptosis.

Beyond cancer, tRNA modifications are implicated in **diabetes**, **obesity**, and **aging**. For example, the levels of queuosine in tRNA are reduced in the liver of diabetic rats, and this reduction is associated with impaired insulin signaling. The modification status of tRNA is also altered during aging, with a general decline in the levels of certain modifications in aged tissues.

## Common Pitfalls and Misconceptions

Students and researchers often encounter several misconceptions about tRNA modifications. Understanding these pitfalls is essential for correctly interpreting experimental data and designing new studies.

### Modifications Are Not Static

A common misconception is that tRNA modifications are constitutive and unchanging. In reality, the levels of many modifications vary in response to cellular conditions, including growth phase, nutrient availability, stress, and differentiation. This dynamic regulation has important consequences for translation and cellular physiology.

For example, the levels of mcm⁵s²U in tRNA^Lys increase under oxidative stress, promoting the translation of stress-response genes. Similarly, the levels of queuosine in tRNA decrease under conditions of oxidative stress, and this decrease is associated with altered translation of specific mRNAs.

When studying tRNA modifications, it is essential to consider the growth conditions and physiological state of the cells. A modification that is present at high levels in exponentially growing cells may be nearly absent in stationary phase or under stress.

### Not All Modifications Are Essential

Another misconception is that all tRNA modifications are essential for viability. In reality, the phenotypic consequences of losing a tRNA modification vary widely. Some modifications are essential for growth, while others have subtle or conditional phenotypes.

For example, the m¹G37 modification of tRNA^Pro is essential in bacteria; cells lacking this modification exhibit severe growth defects due to frameshifting. In contrast, the loss of queuosine in tRNA^Asp, tRNA^Asn, tRNA^His, and tRNA^Tyr has no obvious phenotype in bacteria grown under standard [laboratory conditions](/knowledge/diagnostics/molecular/laboratory-conditions), although it affects the response to oxidative stress.

The variable importance of modifications reflects their different functions. Modifications that are critical for the structural integrity of tRNA or for the accuracy of decoding tend to be essential, while those that fine-tune translation under specific conditions are dispensable under standard growth conditions.

### Distinguishing tRNA Modifications from rRNA and mRNA Modifications

Students often confuse tRNA modifications with modifications found in other RNA species. While the chemical modifications may be identical (e.g., m⁵C is found in tRNA, rRNA, and mRNA), the enzymes that install them, the positions they occupy, and their functions are often different.

For example, m⁵C in tRNA is installed by NSUN2 at position 48, while m⁵C in mRNA is installed by NSUN6 at the 3′ untranslated region. The functional consequences of these modifications are different: m⁵C in tRNA affects tRNA stability and translation, while m⁵C in mRNA affects mRNA stability and translation.

Similarly, pseudouridine is found in tRNA, rRNA, and mRNA, but the enzymes that catalyze its formation are different for each RNA species. The [tRNA Modification](/knowledge/molecular-biology/trna-modification) pathway is distinct from the rRNA and mRNA modification pathways, and it is important to consider each RNA species separately when studying modifications.

## Summary and Future Directions

### Key Takeaways

- Modified bases in tRNA are chemically diverse nucleosides installed post-transcriptionally by dedicated enzymes. More than 150 distinct modifications have been identified across all domains of life.
- Modifications cluster in the anticodon loop (positions 34 and 37) and in the structural core of the tRNA, where they influence decoding accuracy, reading frame maintenance, and tRNA stability.
- The biosynthesis of tRNA modifications is carried out by specific enzymes (writers), which can be regulated by cellular conditions. Some modifications are reversible, with eraser enzymes providing dynamic regulation.
- Modified bases in tRNA are essential for accurate and efficient translation. They restrict or expand wobble pairing, prevent frameshifting, and stabilize the tRNA structure.
- Defects in tRNA modification enzymes cause a range of human diseases, including mitochondrial disorders, neurological conditions, and cancer.
- tRNA modifications are detected using mass spectrometry, high-throughput sequencing, and classical biochemical techniques. Each method has strengths and limitations.

### Unanswered Questions

Despite decades of research, many questions about tRNA modifications remain unanswered. How do modification enzymes achieve their specificity? What are the complete sets of modifications in each tRNA in each organism? How are modification levels regulated in response to cellular signals? What are the functions of the many modifications that have no obvious phenotype when lost?

The emerging field of **epitranscriptomics** aims to address these questions by mapping modifications across the entire transcriptome, including tRNA. Advances in sequencing technology, particularly nanopore sequencing, are making it possible to detect modifications in full-length tRNA molecules with single-molecule resolution.

### Therapeutic Potential

The involvement of tRNA modifications in human disease raises the possibility of therapeutic targeting. Several approaches are being explored:

1. **Small molecule inhibitors** of tRNA modification enzymes could be used to treat cancers in which these enzymes are overexpressed. For example, inhibitors of NSUN2 or TRMT12 might slow tumor growth.

2. **Gene therapy** to deliver functional copies of mutated tRNA modification enzymes could treat mitochondrial diseases and neurological disorders.

3. **Modulation of tRNA modification levels** through dietary interventions could be used to treat conditions associated with altered modification levels. For example, queuosine is obtained from the diet, and supplementation with queuosine precursors might restore normal tRNA function in conditions where queuosine levels are reduced.

The development of these therapeutic approaches requires a deeper understanding of the biology of tRNA modifications, including their functions, regulation, and roles in disease. As our knowledge expands, the potential for clinical translation grows.

## Frequently Asked Questions

### What are modified bases in tRNA?

Modified bases in tRNA are chemically altered nucleosides that are installed post-transcriptionally by specific enzymes. These modifications can be simple (such as the addition of a methyl group) or complex (such as the construction of multi-ring hypermodified bases). They are found at specific positions within the tRNA molecule, most notably in the anticodon loop and the structural core.

### How many modified bases are there in tRNA?

More than 150 distinct modified nucleosides have been identified in tRNA across all domains of life. The number varies by organism; for example, human tRNAs contain approximately 30 different modifications, while some bacterial tRNAs contain fewer. A single tRNA molecule can carry 5–15 modifications at different positions.

### What is the function of modified bases in tRNA?

Modified bases in tRNA have multiple functions. They stabilize the three-dimensional structure of tRNA, protect it from nuclease degradation, ensure accurate codon–anticodon interactions, maintain the reading frame during translation, and regulate translation efficiency. Some modifications also participate in cellular signaling and stress responses.

### How are modified bases in tRNA formed?

Modified bases are formed by enzymes called tRNA modification enzymes, or writers. These enzymes recognize specific positions within the tRNA structure and catalyze the chemical modification of the base or ribose. The reactions require cofactors such as S-adenosylmethionine (SAM) for methylation or dimethylallyl pyrophosphate (DMAPP) for isopentenylation. Some modifications require multiple enzymatic steps.

### Can modified bases in tRNA be removed?

Yes, some tRNA modifications can be removed by eraser enzymes. For example, the AlkB family of dioxygenases can demethylate m¹A and m³C in tRNA. The removal of modifications provides a mechanism for dynamic regulation of tRNA function in response to cellular conditions.

### What diseases are caused by defects in tRNA modifications?

Defects in tRNA modification enzymes cause a range of diseases, including mitochondrial disorders (MELAS, MERRF), neurological conditions (X-linked intellectual disability, autism spectrum disorder, pontocerebellar hypoplasia), and cancer. The severity of the disease depends on the specific modification affected and its importance for tRNA function.

### How are tRNA modifications detected experimentally?

tRNA modifications are detected using several methods. Mass spectrometry (LC-MS/MS) is the gold standard for identifying and quantifying modified nucleosides. High-throughput sequencing methods, such as Pseudo-seq for pseudouridine and DM-tRNA-seq for m¹A, can map modifications to specific positions. Classical biochemical techniques, including 2D-TLC and primer extension, are also used.

## Further Reading

- Reinsch JL, Garcia DM. *Concurrent detection of chemically modified bases in yeast mitochondrial tRNAs by Nanopore direct RNA sequencing*. bioRxiv : the preprint server for biology. 2025. [PubMed 40654949](https://doi.org/10.1101/2025.05.09.653160)
- Motorin Y, Helm M. *tRNA stabilization by modified nucleotides*. Biochemistry. 2010. [PubMed 20459084](https://doi.org/10.1021/bi100408z)
- Perret V et al. *Conformation in solution of yeast tRNA(Asp) transcripts deprived of modified nucleotides*. Biochimie. 1990. [PubMed 2078590](https://doi.org/10.1016/0300-9084(90)90158-d)
- Duechler M et al. *Nucleoside modifications in the regulation of gene expression: focus on tRNA*. Cellular and molecular life sciences : CMLS. 2016. [PubMed 27094388](https://doi.org/10.1007/s00018-016-2217-y)
- Globisch D et al. *Systems-based analysis of modified tRNA bases*. Angewandte Chemie (International ed. in English). 2011. [PubMed 21882308](https://doi.org/10.1002/anie.201103229)
- Sonawane KD, Kamble AS, Fandilolu PM. *Preferences of AAA/AAG codon recognition by modified nucleosides, τm(5)s(2)U(34) and t(6)A(37) present in tRNA(Lys)*. Journal of biomolecular structure & dynamics. 2018. [PubMed 29243556](https://doi.org/10.1080/07391102.2017.1417911)

## Related Topics

- [RNA Binding Protein](/knowledge/molecular-biology/rna-binding-protein)
- [Antisense Oligonucleotide](/knowledge/molecular-biology/antisense-oligonucleotide)
- [Non Coding RNA](/knowledge/molecular-biology/non-coding-rna)
- [Small Nuclear RNA](/knowledge/molecular-biology/small-nuclear-rna)

## Related Clinical & Scientific Guides

* [MAPK Pathway: Mechanism, Function, and Clinical Relevance](/knowledge/molecular-biology/mapk-pathway)
* [Mammalian Cell Culture Bioreactors: A Practical Guide](/knowledge/molecular-biology/mammalian-cell-culture-bioreactor)
* [Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks](/knowledge/molecular-biology/nucleotide-formation)